These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 508127)

  • 21. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache.
    Nelson CF; Bronfort G; Evans R; Boline P; Goldsmith C; Anderson AV
    J Manipulative Physiol Ther; 1998 Oct; 21(8):511-9. PubMed ID: 9798179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 Per Month.
    Kroner JW; Hershey AD; Kashikar-Zuck SM; LeCates SL; Allen JR; Slater SK; Zafar M; Kabbouche MA; O'Brien HL; Shenk CE; Rausch JR; Kroon Van Diest AM; Powers SW
    Headache; 2016 Apr; 56(4):711-6. PubMed ID: 26992129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis.
    Bánk J
    Headache; 1994 Sep; 34(8):476-8. PubMed ID: 7960733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline.
    Nappi G; Sandrini G; Granella F; Ruiz L; Cerutti G; Facchinetti F; Blandini F; Manzoni GC
    Headache; 1990 Jun; 30(7):439-44. PubMed ID: 2119355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
    Max MB; Lynch SA; Muir J; Shoaf SE; Smoller B; Dubner R
    N Engl J Med; 1992 May; 326(19):1250-6. PubMed ID: 1560801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial.
    Friedman BW; Cabral L; Adewunmi V; Solorzano C; Esses D; Bijur PE; Gallagher EJ
    Ann Emerg Med; 2016 Jan; 67(1):32-39.e3. PubMed ID: 26320523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.
    Lampl C; Versijpt J; Amin FM; Deligianni CI; Gil-Gouveia R; Jassal T; MaassenVanDenBrink A; Ornello R; Paungarttner J; Sanchez-Del-Rio M; Reuter U; Uluduz D; de Vries T; Zeraatkar D; Sacco S
    J Headache Pain; 2023 Apr; 24(1):39. PubMed ID: 37038134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches.
    Oguzhanoglu A; Sahiner T; Kurt T; Akalin O
    Cephalalgia; 1999 Jun; 19(5):531-2. PubMed ID: 10403070
    [No Abstract]   [Full Text] [Related]  

  • 33. Migraine prophylaxis with divalproex.
    Mathew NT; Saper JR; Silberstein SD; Rankin L; Markley HG; Solomon S; Rapoport AM; Silber CJ; Deaton RL
    Arch Neurol; 1995 Mar; 52(3):281-6. PubMed ID: 7872882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two different doses of amitriptyline ER in the prophylaxis of migraine: long-term results and predictive factors.
    Lampl C; Huber G; Adl J; Luthringshausen G; Franz G; Marecek S; Weber J; Baumhackl U; Mueller T
    Eur J Neurol; 2009 Aug; 16(8):943-8. PubMed ID: 19456855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial.
    Reidy BL; Peugh J; Hershey AD; Coffey CS; Chamberlin LA; Ecklund DJ; Klingner EA; Yankey JW; Korbee LL; Porter LL; Kabbouche MA; Kacperski J; Powers SW
    Cephalalgia; 2022 Jan; 42(1):44-52. PubMed ID: 34404270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
    Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
    Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
    Aurora SK; Dodick DW; Turkel CC; DeGryse RE; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Cephalalgia; 2010 Jul; 30(7):793-803. PubMed ID: 20647170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind study of dothiepin hydrochloride (Prothiaden) and amitriptyline in out-patients with masked depression.
    Dahl LE; Dencker SJ; Lundin L
    J Int Med Res; 1981; 9(2):103-7. PubMed ID: 7014282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.